Literature DB >> 1339465

Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.

M Tashiro1, J T Seto, S Choosakul, H Hegemann, H D Klenk, R Rott.   

Abstract

Sendai virus mutants, KDe-21 and KDe-62, which had undergone multiple cycles of replication in Madin Darby canine kidney (MDCK) cells in the absence of exogenous proteases were isolated. The fusion (F) protein of the mutants regained proteolytic cleavability in MDCK cells and chick embryos, but the F protein remained non-cleavable in other cell lines. Unlike the F protein of wild-type (wt) virus, the mutant F was resistant to trypsin but was sensitive to elastase and, to a lesser extent, to chymotrypsin. Sequence analyses of the F gene and the F protein revealed an amino acid substitution at the cleavage site, Arg(116) to Ile, which conferred trypsin resistance and enhanced cleavability at Ile(116) by elastase and host proteases present in MDCK cells and in chicken embryos. In contrast to the pneumopathogenicity in mice of wt Sendai virus, the KDe mutants were non-pathogenic; cleavage activation of the F protein did not occur in the lungs and thereby infection was terminated after an initial cycle of replication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1339465     DOI: 10.1099/0022-1317-73-6-1575

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Involvement of the mutated M protein in altered budding polarity of a pantropic mutant, F1-R, of Sendai virus.

Authors:  M Tashiro; N L McQueen; J T Seto; H D Klenk; R Rott
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

2.  Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity.

Authors:  M Tashiro; Y Yokogoshi; K Tobita; J T Seto; R Rott; H Kido
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin.

Authors:  Xiaogang Hou; Edgar Suquilanda; Ana Zeledon; Apollo Kacsinta; Akila Moore; Joseph Seto; Nancy McQueen
Journal:  Med Microbiol Immunol       Date:  2004-06-26       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.